AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Heidelberg Pharma AG

Director's Dealing Jan 13, 2009

201_dirs_2009-01-13_c446bed8-63fd-4e93-a1c8-aac9bfe757db.html

Director's Dealing

Open in Viewer

Opens in native device viewer

News Details

Directors’ Dealings | 13 January 2009 11:27

DGAP-DD: WILEX AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a company of EquityStory AG. The person with duty of notification is solely responsible for the content of this announcement. —————————————————————————— Details of the person subject to the disclosure requirement Last name: Ebsworth First name: David Position: Member of an administrative or supervisory body Information about the transaction with duty of notification Description of the financial instrument: share ISIN/WKN of the financial instrument: DE0006614720 Type of transaction: Purchase Date: 09.01.2009 Price: 3.99 Currency: EUR No. of items: 10000 Total amount traded: 39900.00 Place: Xetra und Frankfurt Explanation for publication: 6,500 shares Xetra, 4.00 € 1,500 shares Frankfurt, 4.00 € 2,000 shares; Xetra, 3.95 € Information about the company with duty of publication Issuer: WILEX AG Grillparzerstr. 10 81675 München Deutschland ISIN: DE0006614720 WKN: 661472 End of Directors’ Dealings Notification (c) DGAP 13.01.2009 Financial News transmitted by DGAP ID 8783

Talk to a Data Expert

Have a question? We'll get back to you promptly.